These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31023721)

  • 1. Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemia.
    Carr RM; Davidson NO
    J Lipid Res; 2019 Jun; 60(6):1067-1068. PubMed ID: 31023721
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Dongiovanni P; Meroni M; Baselli G; Mancina RM; Ruscica M; Longo M; Rametta R; Cespiati A; Pelusi S; Ferri N; Ranzani V; Nobili V; Pihlajamaki J; Fracanzani AL; Badiali S; Petta S; Fargion S; Romeo S; Kozlitina J; Valenti L
    J Lipid Res; 2019 Jun; 60(6):1144-1153. PubMed ID: 30918065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease.
    Chien-Min K; Cheng-Chuan L
    Ann Clin Lab Sci; 2017 Mar; 47(2):191-200. PubMed ID: 28442522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
    Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
    Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
    Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
    Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA
    J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death.
    Paiva AA; Raposo HF; Wanschel AC; Nardelli TR; Oliveira HC
    Oxid Med Cell Longev; 2017; 2017():1838679. PubMed ID: 28163820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are statins 'IDEAL' for non-alcoholic fatty liver disease?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2014 Feb; 30(2):229-31. PubMed ID: 24127654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates.
    Goedeke L; Peng L; Montalvo-Romeral V; Butrico GM; Dufour S; Zhang XM; Perry RJ; Cline GW; Kievit P; Chng K; Petersen KF; Shulman GI
    Sci Transl Med; 2019 Oct; 11(512):. PubMed ID: 31578240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidaemia: Hypertriglyceridaemia caused by GPIHBP1 autoantibodies.
    Lim GB
    Nat Rev Cardiol; 2017 Jun; 14(6):316-317. PubMed ID: 28436485
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatty liver diseases, mechanisms, and potential therapeutic plant medicines.
    Zhu JZ; Yi HW; Huang W; Pang T; Zhou HP; Wu XD
    Chin J Nat Med; 2020 Mar; 18(3):161-168. PubMed ID: 32245585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
    Scorletti E; Byrne CD
    Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L; Rebollo A; Ađalsteisson GS; Alegret M; Merlos M; Roglans N; Laguna JC
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):32-40. PubMed ID: 21122807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
    Andrés-Blasco I; Herrero-Cervera A; Vinué Á; Martínez-Hervás S; Piqueras L; Sanz MJ; Burks DJ; González-Navarro H
    J Endocrinol; 2015 Dec; 227(3):179-91. PubMed ID: 26423094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.
    Quiroga AD; Comanzo CG; Heit Barbini FJ; Lucci A; Vera MC; Lorenzetti F; Ferretti AC; Ceballos MP; Alvarez ML; Carrillo MC
    Toxicol Appl Pharmacol; 2019 Sep; 379():114650. PubMed ID: 31299271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity).
    Panneerselvam S; Packirisamy RM; Bobby Z; Elizabeth Jacob S; Sridhar MG
    J Nutr Biochem; 2016 Dec; 38():57-69. PubMed ID: 27723468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.